The former pharmaceutical company CEO was convicted of securities fraud. A federal judge has rejected a request from Martin Shkreli, the infamous "Pharma Bro" fraudster, for a compassionate release ...

NEW YORK — A federal appeals court upheld the securities fraud conviction against former drug company CEO Martin Shkreli, known as “Pharma Bro,” on Thursday, along with a $7.3 million forfeiture of ...

NEW YORK CITY -- Martin Shkreli, the eccentric former pharmaceutical CEO notorious for a price-gouging scandal and for his snide "Pharma Bro" persona on social media, was convicted Friday on federal ...

In a significant legal development, the U.S. Supreme Court has denied Martin Shkreli’s appeal to overturn a $64.6 million repayment order. This decision marks another setback for the former ...

Companies founded by notorious "Pharma Bro" Martin Shkreli have agreed to pay up to $28 million to settle a class-action lawsuit related to claims they illegally thwarted competition to the ...

In this Aug. 3, 2017, file photo, Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, arrives at federal court in Brooklyn, New York. automation Martin Shkreli's lifetime ban ...

The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the price of a lifesaving drug. Shkreli appealed an order to return $64.6 million ...

A journalist who covered Martin Shkreli says she gave up everything for the notorious "Pharma Bro." In a viral interview with Elle Magazine, former Bloomberg News reporter Christie Smythe says she did ...

Once convicted of securities fraud, Shkreli now focuses primarily on stock trading. He shared a short position in Opendoor on X this week, drawing the ire of bullish retail investors. Martin Shkreli ...

Cassava Sciences (NASDAQ:SAVA) stock is falling Monday after the company shared an update on its Phase 3 trial for a treatment for Alzheimer's disease that has been widely followed by the market.